Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.
Saved in:
| Title: | Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial. |
|---|---|
| Authors: | Icht O; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Gray Faculty of Medicine and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Sun A; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Wong P; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., McPartlin A; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Muniz TP; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Spreafico A; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Saibil SD; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lukens JN; University of Pennsylvania, Philadelphia, PA, United States., Karam SD; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, United States., De Almeida J; Department of Otolaryngology-Head and Neck Surgery, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada., Butler MO; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Tsai CJ; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Jul 06; Vol. 16, pp. 1841070. Date of Electronic Publication: 2026 Jul 06 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
